<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rehab</journal-id><journal-title-group><journal-title xml:lang="ru">Реабилитология</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of Medical Rehabilitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2949-5873</issn><issn pub-type="epub">2949-5881</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2949-5873/rehabil.2024.22</article-id><article-id custom-type="elpub" pub-id-type="custom">rehab-23</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group></article-categories><title-group><article-title>Организация реабилитации при злокачественных новообразованиях репродуктивной системы</article-title><trans-title-group xml:lang="en"><trans-title>Organization of rehabilitation for reproductive system malignant neoplasms</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9212-3865</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Александров</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Aleksandrov</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Александров Андрей Георгиевич - к.б.н. Scopus Author ID: 57211350219.</p><p>Ул. Садовая-Триумфальная, д. 4/10, Москва 127006; ул. Быкова, д. 84Б, Ленинградская обл., Всеволожский р-н, Колтушское с/п, с. Павлово 188680</p></bio><bio xml:lang="en"><p>Andrey G. Aleksandrov – PhD. Scopus Author ID: 57211350219.</p><p>4/10 Sadovaya-Triumfalnaya Str., Moscow 127006; 84B Bykov Str., Leningrad Region, Vsevolozhsk District, Koltushskoye Rural Settlement, Pavlovo 188680</p></bio><email xlink:type="simple">andrey.alexandrov@ipsom.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт Превентивной и Социальной Медицины; Центр доклинических исследований «Фармакоген»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute for Preventive and Social Medicine; “Pharmacogen” Center for Preclinical Research</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>10</day><month>09</month><year>2024</year></pub-date><volume>2</volume><issue>2</issue><fpage>247</fpage><lpage>263</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Александров А.Г., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Александров А.Г.</copyright-holder><copyright-holder xml:lang="en">Aleksandrov A.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rehabilitology.com/jour/article/view/23">https://www.rehabilitology.com/jour/article/view/23</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Достижения медицины позволили существенно увеличить продолжительность жизни пациенток с онкогинекологическими заболеваниями. На текущий момент одной из ключевых задач системы здравоохранения является восстановление и поддержание качества жизни онкологических больных, что актуализирует вопросы оптимизации системы реабилитации.</p></sec><sec><title>Цель</title><p>Цель: представить особенности организации реабилитационных мероприятий у пациенток с онкологическими заболеваниями гинекологического профиля.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В обзор включено 75 публикаций на русском и английском языках, найденных в научных базах данных PubMed/MEDLINE, Google Scholar, ScienceDirect и онлайн-библиотеках eLibrary, КиберЛенинка, Cochrane Library, а также на сайтах научных сообществ и организаций. Отбор публикаций проведен с учетом рекомендаций PRISMA.</p></sec><sec><title>Результаты</title><p>Результаты. Порядок оказания реабилитационной помощи пациенткам онкогинекологического профиля в отдельных аспектах схож с таковым при других онкологических заболеваниях. Показана эффективность нутритивной поддержки, лечебной физической культуры, физиотерапии и психологической помощи в восстановлении качества жизни и предотвращении развития осложнений. При проявлении дистресса, глубоких негативных психоэмоциональных нарушений, влияющих на физиологические процессы организма, хороший эффект оказывают йога, арт-терапия, когнитивно поведенческая терапия, гипнотерапия, трудотерапия и танцевально-двигательная терапия. Однако реабилитация у пациенток с онкологическими заболеваниями репродуктивных органов имеет ряд особенностей: необходимо проводить мониторинг состояния сексуальной функции и развития болевого синдрома, а также оказывать персонифицированную реабилитационную помощь. Данная специфика связана с изменениями гормонального фона, осложнениями после хирургического вмешательства и закрытостью пациенток при обсуждении вопросов сексуального здоровья.</p></sec><sec><title>Заключение</title><p>Заключение. Реабилитация женщин после лечения онкогинекологических заболеваний восстанавливает утраченное благополучие, однако текущих мер поддержки недостаточно. Оказание комплексной персонифицированной реабилитации таким пациенткам в России не носит обязательного характера, что сказывается на длительности и эффективности восстановления здоровья женщин. Дальнейшее развитие реабилитационной помощи, в т.ч. через повсеместное внедрение комплексной реабилитации, позволит повысить ее качество и снизить финансовую нагрузку на систему здравоохранения.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. The advances in medicine have significantly improved the life expectancy for patients with gynecologic oncology. Currently, one of the key tasks of the healthcare system is to restore and maintain the quality of life of cancer patients, which actualizes the issues of optimizing the rehabilitation system.</p></sec><sec><title>Objective</title><p>Objective: to present the features of organizing rehabilitation activities for female patients with gynecological oncological diseases.</p></sec><sec><title>Material and methods</title><p>Material and methods. The review included 75 Russian and English publications found in the scientific databases PubMed/ MEDLINE, Google Scholar, ScienceDirect and online libraries eLibrary, CyberLeninka, Cochrane Library as well as on websites of scientific communities and organizations. The selection of publications was carried out according to PRISMA recommendations.</p></sec><sec><title>Results</title><p>Results. The procedure for providing rehabilitation care to patients of oncogynecological profile is similar in some aspects to that of other oncological diseases. The effectiveness of nutritional support, therapeutic physical culture, physiotherapy and psychological assistance in restoring quality of life and preventing the development of complications was demonstrated. In case of distress, deep negative psycho-emotional manifestations affecting the physiological processes of the body, yoga, art therapy, cognitive-behavioral therapy, hypnotherapy, occupational therapy and dance-movement therapy exert a good effect. However, rehabilitation in patients with oncological diseases of reproductive organs has a number of features: it is necessary to monitor the state of their sexual function and the development of pain syndrome. Besides, there is a request for personalized rehabilitation assistance. This specificity is related to changed hormonal status, complications after surgery and the patients’ closeness in discussing sexual health issues.</p></sec><sec><title>Conclusion</title><p>Conclusion. Rehabilitation of women after treatment for oncogynecological diseases restores lost well-being, however, current measures of support are not enough. The provision of comprehensive personalized rehabilitation to such patients in Russia is not mandatory, which affects the duration and effectiveness of their health restoration. Further development of rehabilitation care, including through widespread implementation of comprehensive rehabilitation, will improve its quality and reduce the financial burden on the healthcare system.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>Гинекология</kwd><kwd>рак</kwd><kwd>реабилитация</kwd><kwd>особенности</kwd><kwd>осложнения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Gynecology</kwd><kwd>cancer</kwd><kwd>rehabilitation</kwd><kwd>features</kwd><kwd>complications</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Автор заявляет об отсутствии финансовой поддержки</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sung H., Ferlay J., Siegel R.L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71 (3): 209–49. https://doi.org/10.3322/caac.21660.</mixed-citation><mixed-citation xml:lang="en">Sung H., Ferlay J., Siegel R.L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71 (3): 209–49. https://doi.org/10.3322/caac.21660.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А.Д., Старинский В.В., Шахзадова А.О. (ред.) Состояние онкологической помощи населению России в 2021 году. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2022: 239 с.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinskiy V.V., Shakhzadova A.O. (Eds.) The state of oncological care for the population of Russia in 2021. Мoscow: Herzen Moscow Research Oncological Institute – branch of National Medical Research Center of Radiology; 2022: 239 pp. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat REV Clin Oncol. 2021; 18 (10): 663–72. https://doi.org/10.1038/s41571-021-00514-z.</mixed-citation><mixed-citation xml:lang="en">Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat REV Clin Oncol. 2021; 18 (10): 663–72. https://doi.org/10.1038/s41571-021-00514-z.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Власина А.Ю., Идрисова Л.Э., Солопова А.Г. и др. Реабилитация онкогинекологических больных после противоопухолевой терапии: пути решения. Акушерство, гинекология и репродукция. 2020; 14 (1): 44–55. https://doi.org/10.17749/2313-7347.2020.14.1.44-55.</mixed-citation><mixed-citation xml:lang="en">Vlasina A.V., Idrisova L.E., Solopova A.G., et al. Rehabilitation of oncogynecological patients after antitumor therapy: ways of solution. Obstetrics, Gynecology and Reproduction. 2020; 14 (1): 44–55 (in Russ.). https://doi.org/10.17749/2313-7347.2020.14.1.44-55.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Кузнецова И.В. (ред.) Адъювантная и альтернативная терапия в акушерстве и гинекологии. М.: ИндексМед Медиа; 2018: 434 с.</mixed-citation><mixed-citation xml:lang="en">Kuznetsova I.V. (Ed.) Adjuvant and alternative therapy in obstetrics and gynecology. Мoscow: IndexMed Media; 2018: 434 pp. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Contreras N.A., Sabadell J., Verdaguer P., et al. Fertility-sparing approaches in atypical endometrial hyperplasia and endometrial cancer patients: current evidence and future directions. Int J Mol Sci. 2022; 23 (5): 2531. https://doi.org/10.3390/ijms23052531.</mixed-citation><mixed-citation xml:lang="en">Contreras N.A., Sabadell J., Verdaguer P., et al. Fertility-sparing approaches in atypical endometrial hyperplasia and endometrial cancer patients: current evidence and future directions. Int J Mol Sci. 2022; 23 (5): 2531. https://doi.org/10.3390/ijms23052531.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Кузнецова И.В., Покуль Л.В., Бурчаков Д.И. и др. Терапия и профилактика нарушений здоровья у женщин старше 40 лет. М.: ИндексМед Медиа; 2017: 192 c.</mixed-citation><mixed-citation xml:lang="en">Kuznetsova I.V., Pokul’ L.V., Burchakov D.I., et al. Therapy and prevention of health disorders in women over 40 years of age. Мoscow: IndexMed Media; 2017: 192 pp. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Stevenson J.C., Abeyasekera G., Hillyard C.J., et al. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet. 1981; 1 (8222): 693–5. https://doi.org/10.1016/s0140-6736(81)91973-5.</mixed-citation><mixed-citation xml:lang="en">Stevenson J.C., Abeyasekera G., Hillyard C.J., et al. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet. 1981; 1 (8222): 693–5. https://doi.org/10.1016/s0140-6736(81)91973-5.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Доброхотова Ю.Э., Хлынова С.А. Использование лубрикантов при вульвовагинальной атрофии. Русский медицинский журнал. Мать и дитя. 2018; 1 (2): 163–7. https://doi.org/10.32364/2618-84302018-1-2-163-167.</mixed-citation><mixed-citation xml:lang="en">Dobrokhotova Yu.E., Khlynova S.A. Lubricants application in vulvovaginal atrophy.russian Journal of Woman and Child Health. 2018; 1 (2): 163–7 (in Russ.). https://doi.org/10.32364/2618-84302018-1-2-163-167.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Griesser H., Skonietzki S., Fischer T., et al. Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebocontrolled trial investigating the efficacy of pessaries containing 0.2 mg and 0.03 mg estriol. Maturitas. 2012; 71 (4): 360–8. https://doi.org/10.1016/j.maturitas.2011.12.022.</mixed-citation><mixed-citation xml:lang="en">Griesser H., Skonietzki S., Fischer T., et al. Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebocontrolled trial investigating the efficacy of pessaries containing 02 mg and 0.03 mg estriol. Maturitas. 2012; 71 (4): 360–8. https://doi.org/10.1016/j.maturitas.2011.12.022.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Crane T.E., Khulpateea B.R., Alberts D.S., et al. Dietary intake and ovarian cancer risk: a systematic review. Cancer Epidemiol Biomarkers PREV. 2014; 23 (2): 255–73. https://doi.org/10.1158/1055-9965.EPI-130515.</mixed-citation><mixed-citation xml:lang="en">Crane T.E., Khulpateea B.R., Alberts D.S., et al. Dietary intake and ovarian cancer risk: a systematic review. Cancer Epidemiol Biomarkers PREV. 2014; 23 (2): 255–73. https://doi.org/10.1158/1055-9965.EPI-130515.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmadieh H., Jradi N. Prevalence of menopausal hot flashes in Lebanon: a cross-sectional study. Int J Reprod Biomed. 2021; 19 (9): 789–800. https://doi.org/10.18502/ijrm.v19i9.9711.</mixed-citation><mixed-citation xml:lang="en">Ahmadieh H., Jradi N. Prevalence of menopausal hot flashes in Lebanon: a cross-sectional study. Int J Reprod Biomed. 2021; 19 (9): 789–800. https://doi.org/10.18502/ijrm.v19i9.9711.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kaur H., Merchant M., Haque M.M., Mande S.S. Crosstalk between female gonadal hormones and vaginal microbiota across various phases of women’s gynecological lifecycle. Front Microbiol. 2020; 11: 551. https://doi.org/10.3389/fmicb.2020.00551.</mixed-citation><mixed-citation xml:lang="en">Kaur H., Merchant M., Haque M.M., Mande S.S. Crosstalk between female gonadal hormones and vaginal microbiota across various phases of women’s gynecological lifecycle. Front Microbiol. 2020; 11: 551. https://doi.org/10.3389/fmicb.2020.00551.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Кира Е.Ф. Роль пробиотиков в лечении инфекций влагалища. Российский вестник акушера-гинеколога. 2010; 10 (5): 33–9.</mixed-citation><mixed-citation xml:lang="en">Kira E.F. Role of probiotics in the treatment of vaginal infections. Russian Bulletin of Obstetrician-Gynecologist. 2010; 10 (5): 33–9 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Уруймагова А.Т., Прилепская В.Н., Межевитинова Е.А. и др. Бактериальный вагиноз: современные представления о диагностике и лечении. Гинекология. 2021; 23 (4): 286–93. https://doi.org/10.26442/20795696.2021.4.200954.</mixed-citation><mixed-citation xml:lang="en">Uruimagova A.T., Prilepskaya V.N., Mezhevitinova E.A., et al. Bacterial vaginosis: modern concepts, approaches to diagnosis and treatment. Gynecology. 2021; 23 (4): 286–93 (in Russ.). https://doi.org/10.26442/20795696.2021.4.200954.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kushi L.H., Doyle C., McCullough M., et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012; 62 (1): 30–67. https://doi.org/10.3322/caac.20140.</mixed-citation><mixed-citation xml:lang="en">Kushi L.H., Doyle C., McCullough M., et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012; 62 (1): 30–67. https://doi.org/10.3322/caac.20140.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Г., Власина А.Ю., Идрисова Л.Э. и др. Реабилитация онкогинекологических больных: актуальные проблемы и возможные решения. Вестник восстановительной медицины. 2019; 5: 87–96.</mixed-citation><mixed-citation xml:lang="en">Solopova A.G., Vlasina A.Y., Idrisova L.E., et al. Rehabilitation of oncogynecological patients: current problems and possible solutions. Bulletin of Rehabilitation Medicine. 2019; 5: 87–96 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Г., Идрисова Л.Э., Макацария А.Д. и др. Мультидисциплинарный подход к медицинской реабилитации онкогинекологических больных. Акушерство, гинекология и репродукция. 2017; 11 (4): 57–67. https://doi.org/10.17749/2313-7347.2017.11.4.057-067.</mixed-citation><mixed-citation xml:lang="en">Solopova A.G., Idrisova L.E., Makatsariya A.D., et al. Multidisciplinary approach to medical rehabilitation of oncogynecologic patients. Obstetrics, Gynecology and Reproduction. 2017; 11 (4): 57–67 (in Russ.). https://doi.org/10.17749/2313-7347.2017.11.4.057-067.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Грушина Т.И., Куликов А.Г. Методы физической терапии в реабилитации больных раком молочной железы III клинической группы с постмастэктомическим отеком (часть I). Физиотерапия, бальнеология и реабилитация. 2015; 14 (5): 46–51.</mixed-citation><mixed-citation xml:lang="en">Grushina T.I., Kulikov A.G. The application of physiotherapeutic methods for the rehabilitation of the women presenting with breast cancer of clinical group III with post-mastectomy oedema (part I).russian Journal of Physiotherapy, Balneology and Rehabilitation. 2015; 14 (5): 46–51 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Генс Г.П., Сирота Н.А., Олейникова И.Н. Влияние дистресса на качество жизни у больных раком яичников. Злокачественные oпухоли. 2017; 7 (3S1): 166–8.</mixed-citation><mixed-citation xml:lang="en">Gens G.P., Sirota N.A., Oleynikova I.N. The effect of distress on the quality of life of ovarian cancer patients. Malignant Tumours. 2017; 7 (3S1): 166–8 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Кузьмина И.В., Раковская Д.Н. Психологическая помощь онкологическим больным на этапах комбинированного лечения. Онкология. Журнал им. П.А. Герцена. 2019; 8 (4): 316–20. https://doi.org/10.17116/onkolog20198041316.</mixed-citation><mixed-citation xml:lang="en">Kuzmina I.V., Rakovskaya D.N. Psychological care to cancer patients at the stages of combined treatment. Onkologiya. Zhurnal imeni P.A. Gertsena / P.A. Herzen Journal of Oncology. 2019; 8 (4): 316–20 (in Russ.). https://doi.org/10.17116/onkolog20198041316.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Степанова А.М., Мерзлякова А.М., Ткаченко Г.А., Кашия Ш.Р. Физиотерапия, механотерапия и психотерапия в онкологии. Вестник восстановительной медицины. 2016; 5: 42–6.</mixed-citation><mixed-citation xml:lang="en">Stepanova A.M., Merzljakova A.M., Tkachenko G.A., Kashiya Sh.R. Physiotherapy, physical therapy and psychotherapy in oncology. Bulletin of Rehabilitation Medicine. 2016; 5: 42–6 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Чевычелова О.Н., Теплоухова Ю.И., Орлова Е.М. Танцевально-двигательная терапия в реабилитации онкологических пациентов. В кн.: Гуляев Г.Ю. (ред.) Научные достижения и открытия 2019: сборник статей X Международного научно-исследовательского конкурса. Пенза: Наука и просвещение; 2019: 216–8.</mixed-citation><mixed-citation xml:lang="en">Chevychelova O.N., Teploukhova Yu.I., Orlova E.M. Dance and movement therapy in the rehabilitation of cancer patients. In: Gulyaev G.Yu. (Ed.) Scientific achievements and discoveries 2019: collection of articles of the X International Scientific Research Competition. Penza: Nauka i prisveshchenie; 2019: 216–8 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Аржаненкова Л.С., Сычов М.Д. Вопросы трудовой реабилитации в медико-социальной экспертизе онкогинекологических больных. Кубанский научный медицинский вестник. 2007; 1–2: 17–8.</mixed-citation><mixed-citation xml:lang="en">Arzhanenkova L.S., Sychov M.D. Questions of professional rehabilitation in medical-social examination of the patients with malignant tumors female reproductions of system. Kuban Scientific Medical Bulletin. 2007; 1–2: 17–8 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ткаченко Г.А. Арт-терапия в комплексной реабилитации онкологических больных. Физическая и реабилитационная медицина, медицинская реабилитация. 2019; 1 (3): 37–9. https://doi.org/10.36425/2658-6843-2019-3-37-39.</mixed-citation><mixed-citation xml:lang="en">Tkachenko G.A. Art therapy in complex rehabilitation of cancer patients. Physical and Rehabilitation Medicine, Medical Rehabilitation. 2019; 1 (3): 37–9 (in Russ.). https://doi.org/10.36425/2658-6843-2019-3-37-39.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Сердюкова Е.Ф. Десенсибилизация и переработка движениями глаз как экспресс-помощь в работе с негативным жизненным опытом. Вестник Костромского государственного университета. Серия: Педагогика. Психология. Cоциокинетика. 2015; 21 (2): 99–101.</mixed-citation><mixed-citation xml:lang="en">Serdyukova Ye.F. Desensitisation and processing of eye movements as a rapid assistance in dealing with the negative experiences. Vestnik of Kostroma State UNIVERSITY. Series: Pedagogy. Psychology. Sociokinetics. 2015; 21 (2): 99–101 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Chu I.H., Lin Y.J., Wu W.L., et al. Effects of yoga on heart rate variability and mood in women: a randomized controlled trial. J Altern Complement Med. 2015; 21 (12): 789–95. https://doi.org/10.1089/acm.2015.0138.</mixed-citation><mixed-citation xml:lang="en">Chu I.H., Lin Y.J., Wu W.L., et al. Effects of yoga on heart rate variability and mood in women: a randomized controlled trial. J Altern Complement Med. 2015; 21 (12): 789–95. https://doi.org/10.1089/acm.2015.0138.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Chu I.H., Wu W.L., Lin I.M., et al. Effects of yoga on heart rate variability and depressive symptoms in women: a randomized controlled trial. J Altern Complement Med. 2017; 23 (4): 310–6. https://doi.org/10.1089/acm.2016.0135.</mixed-citation><mixed-citation xml:lang="en">Chu I.H., Wu W.L., Lin I.M., et al. Effects of yoga on heart rate variability and depressive symptoms in women: a randomized controlled trial. J Altern Complement Med. 2017; 23 (4): 310–6. https://doi.org/10.1089/acm.2016.0135.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Pauls R.N. Impact of gynecological surgery on female sexual function. Int J Impot Res. 2010; 22 (2): 105–14. https://doi.org/10.1038/ijir.2009.63.</mixed-citation><mixed-citation xml:lang="en">Pauls R.N. Impact of gynecological surgery on female sexual function. Int J Impot Res. 2010; 22 (2): 105–14. https://doi.org/10.1038/ijir.2009.63.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Stabile C., Gunn A., Sonoda Y., Carter J. Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer. Transl Androl Urol. 2015; 4 (2): 169–85. https://doi.org/10.3978/j.issn.2223-4683.2015.04.03.</mixed-citation><mixed-citation xml:lang="en">Stabile C., Gunn A., Sonoda Y., Carter J. Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer. Transl Androl Urol. 2015; 4 (2): 169–85. https://doi.org/10.3978/j.issn.2223-4683.2015.04.03.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Denton A.S., Maher J. Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database Syst REV. 2003; 2003 (1): CD003750. https://doi.org/10.1002/14651858.CD003750.</mixed-citation><mixed-citation xml:lang="en">Denton A.S., Maher J. Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database Syst REV. 2003; 2003 (1): CD003750. https://doi.org/10.1002/14651858.CD003750.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Flay L.D., Matthews J.H. The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int J Radiat Oncol Biol Phys. 1995; 31 (2): 399–404. https://doi.org/10.1016/03603016(94)E0139-B.</mixed-citation><mixed-citation xml:lang="en">Flay L.D., Matthews J.H. The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int J Radiat Oncol Biol Phys. 1995; 31 (2): 399–404. https://doi.org/10.1016/03603016(94)E0139-B.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Reis D., Jones T. Aromatherapy: using essential oils as a supportive therapy. Clin J Oncol Nurs. 2017; 21 (1): 16–9. https://doi.org/10.1188/17.CJON.16-19.</mixed-citation><mixed-citation xml:lang="en">Reis D., Jones T. Aromatherapy: using essential oils as a supportive therapy. Clin J Oncol Nurs. 2017; 21 (1): 16–9. https://doi.org/10.1188/17.CJON.16-19.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Лутошкина М.Г. Физические факторы в комплексном лечении и реабилитации пациентов с хронической венозной недостаточностью. Физиотерапия, бальнеология и реабилитация. 2004; 1: 48–54.</mixed-citation><mixed-citation xml:lang="en">Lutoshkina M.G. Physical factors in combined treatment and rehabilitation of patients with chronic venous insufficiency. Journal of Physiotherapy, Balneology and Rehabilitation. 2004; 1: 48–54 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Thomaz J.P., Dias T.D.S.M., de Rezende L.F. Effect of taping as treatment to reduce breast cancer lymphedema: literature review. J Vasc Bras. 2018; 17 (2): 136–40. https://doi.org/10.1590/16775449.007217.</mixed-citation><mixed-citation xml:lang="en">Thomaz J.P., Dias T.D.S.M., de Rezende L.F. Effect of taping as treatment to reduce breast cancer lymphedema: literature review. J Vasc Bras. 2018; 17 (2): 136–40. https://doi.org/10.1590/16775449.007217.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Потиевская В.И., Шветский Ф.М., Сидоров Д.В. и др. Оценка влияния ксенона на интенсивность послеоперационного болевого синдрома у онкологических пациентов: рандомизированное исследование. Вестник интенсивной терапии им. А.И. Салтанова. 2021; 3: 140–50. https://doi.org/10.21320/1818-474X-2021-3-140-150.</mixed-citation><mixed-citation xml:lang="en">Potievskaya V.I., Shvetskiy F.M., Sidorov D.V., et al. Assessment of xenon effect on postoperative pain syndrome severity in oncological patients: a randomized study. Annals of Critical Care. 2021; 3: 140–50 (in Russ.). https://doi.org/10.21320/1818-474X-2021-3-140-150.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Sanders R.D., Ma D., Maze M. Xenon: elemental anaesthesia in clinical practice. Br Med Bull. 2005; 71 (1): 115–35. https://doi.org/10.1093/bmb/ldh034.</mixed-citation><mixed-citation xml:lang="en">Sanders R.D., Ma D., Maze M. Xenon: elemental anaesthesia in clinical practice. Br Med Bull. 2005; 71 (1): 115–35. https://doi.org/10.1093/bmb/ldh034.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Кит О.И., Попова Н.Н., Шихлярова А.И. и др. Развитие посткастрационного синдрома и корригирующее действие ксенона в экспоненциальном дозовом режиме у пациенток молодого возраста с онкопатологией репродуктивных органов. Южно-Российский онкологический журнал. 2020; 1 (3): 6–17. https://doi.org/10.37748/2687-0533-2020-1-3-1.</mixed-citation><mixed-citation xml:lang="en">Kit O.I., Popova N.N., Shikhlyarova A.I., et al. Development of postcastration syndrome and corrective effect of xenon in exponential dose regimen in young patients with gynecological cancers. South Russian Journal of Cancer. 2020; 1 (3): 6–17 (in Russ.). https://doi.org/10.37748/2687-0533-2020-1-3-1.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Когония Л.М., Новиков Г.А., Орлова Р.В. и др. Практические рекомендации по лечению хронического болевого синдрома у взрослых онкологических больных. Злокачественные oпухоли. 2021; 11 (3s2-2): 167–86. https://doi.org/10.18027/2224-5057-2021-11-3s2-49.</mixed-citation><mixed-citation xml:lang="en">Kogonia L.M., Novikov G.A., Orlova R.V., et al. Practical recommendations for the treatment of chronic pain syndrome in adult cancer patients. Malignant Tumours. 2021; 11 (3s2-2): 167–86 (in Russ.). https://doi.org/10.18027/2224-5057-2021-11-3s2-49.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Hasan S.S., Vasant D. The emerging new reality of hypnosis teletherapy: a major new mode of delivery of hypnotherapy and clinical hypnosis training. Int J Clin Exp Hypn. 2023; 71 (2): 153–64. https://doi.org/10.1080/00207144.2023.2185527.</mixed-citation><mixed-citation xml:lang="en">Hasan S.S., Vasant D. The emerging new reality of hypnosis teletherapy: a major new mode of delivery of hypnotherapy and clinical hypnosis training. Int J Clin Exp Hypn. 2023; 71 (2): 153–64. https://doi.org/10.1080/00207144.2023.2185527.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Hasan S.S., Pearson J.S., Morris J., Whorwell P.J. Skype hypnotherapy for irritable bowel syndrome: effectiveness and comparison with face-to-face treatment. Int J Clin Exp Hypn. 2019; 67 (1): 69–80. https://doi.org/10.1080/00207144.2019.1553766.</mixed-citation><mixed-citation xml:lang="en">Hasan S.S., Pearson J.S., Morris J., Whorwell P.J. Skype hypnotherapy for irritable bowel syndrome: effectiveness and comparison with face-to-face treatment. Int J Clin Exp Hypn. 2019; 67 (1): 69–80. https://doi.org/10.1080/00207144.2019.1553766.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Котова З.С., Семиглазова Т.Ю., Балдуева И.А. и др. Эфферентная терапия в первой линии лекарственного лечения метастатического колоректального рака. Медицинский cовет. 2018; 10: 172–5. https://doi.org/10.21518/2079-701X-2018-10-172-175.</mixed-citation><mixed-citation xml:lang="en">Kotova Z.S., Semiglazova T.Y., Baldueva I.A., et al. Efferent therapy in the first-line drug treatment of metastatic colorectal cancer. Meditsinskiy SOVET / Medical Council. 2018; 10: 172–5 (in Russ.). https://doi.org/10.21518/2079-701X-2018-10-172-175.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Латипова Д.Х., Проценко С.А., Новик А.В. и др. Место эфферентной терапии в лечении солидных опухолей. Вопросы oнкологии. 2015; 61 (2): 174–9.</mixed-citation><mixed-citation xml:lang="en">Latipova D.Kh., Protsenko S.A., Novik A.V., et al. The role of efferent therapy in treatment of solid tumors. Problems in Oncology. 2015; 61 (2): 174–9 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Gernier F., Ahmed-Lecheheb D., Pautier P., et al. Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors. BMC Cancer. 2021; 21 (1): 1147. https://doi.org/10.1186/s12885-021-08864-8.</mixed-citation><mixed-citation xml:lang="en">Gernier F., Ahmed-Lecheheb D., Pautier P., et al. Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors. BMC Cancer. 2021; 21 (1): 1147. https://doi.org/10.1186/s12885-021-08864-8.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Deng G. Integrative medicine therapies for pain management in cancer patients. Cancer J. 2019; 25 (5): 343–8. https://doi.org/10.1097/PPO.0000000000000399.</mixed-citation><mixed-citation xml:lang="en">Deng G. Integrative medicine therapies for pain management in cancer patients. Cancer J. 2019; 25 (5): 343–8. https://doi.org/10.1097/PPO.0000000000000399.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Fu T., Guang H.J., Gao X.Z. Percutaneous nerve electrical stimulation for fatigue caused by chemotherapy for cervical cancer. Medicine. 2018; 97 (41): e12020. https://doi.org/10.1097/MD.0000000000012020.</mixed-citation><mixed-citation xml:lang="en">Fu T., Guang H.J., Gao X.Z. Percutaneous nerve electrical stimulation for fatigue caused by chemotherapy for cervical cancer. Medicine. 2018; 97 (41): e12020. https://doi.org/10.1097/MD.0000000000012020.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Укрепление реабилитации в системах здравоохранения. Всемирная организация здравоохранения. 28 декабря 2022 г. URL: https://apps.who.int/gb/ebwha/pdf_files/EB152/B152_8-ru.pdf (дата обращения 23.06.2023).</mixed-citation><mixed-citation xml:lang="en">Strengthening rehabilitation in health systems. World Health Organization. 28 December 2022. Available at: https://apps.who.int/gb/ebwha/pdf_files/EB152/B152_8-en.pdf (accessed 23.06.2023).</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Самойлова И.Г. Экономическая эффективность реабилитации детей после нейроинфекций. Вятский медицинский вестник. 2019; 1: 64–6.</mixed-citation><mixed-citation xml:lang="en">Samoilova I.G. Economic efficiency of rehabilitation in children after neuroinfections. Medical Newsletter of Vyatka. 2019; 1: 64–6 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Rehabilitation 2030: a call for action: 6–7 February 2017, Executive Boardroom, WHO Headquarters, Meeting Report. World Health Organization. 2020. URL: https://iris.who.int/handle/10665/339910 (дата обращения 30.09.2023).</mixed-citation><mixed-citation xml:lang="en">Rehabilitation 2030: a call for action: 6–7 February 2017, Executive Boardroom, WHO Headquarters, Meeting Report. World Health Organization. 2020. Available at: https://iris.who.int/handle/10665/339910 (accessed 30.09.2023).</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Е., Чащин А.А., Солопова А.Г., Макацария А.Д. Эпителиальный рак яичников. Клиническая лекция. Акушерство, гинекология и репродукция. 2016; 10 (3): 53–65. https://doi.org/10.17749/2313-7347.2016.10.2.053-065.</mixed-citation><mixed-citation xml:lang="en">Solopova A.E., Chashchin A.A., Solopova A.G., Makatsariya A.D. Epithelial ovarian cancer. Clinical lecture. Obstetrics, Gynecology and Reproduction. 2016; 10 (3): 53–65 (in Russ.). https://doi.org/10.17749/2313-7347.2016.10.2.053-065.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Walentowicz-Sadlecka M., Grabiec M., Sadlecki P., et al. 25(OH)D3 in patients with ovarian cancer and its correlation with survival. Clin Biochem. 2012; 45 (18): 1568–72. https://doi.org/10.1016/j.clinbiochem.2012.07.110.</mixed-citation><mixed-citation xml:lang="en">Walentowicz-Sadlecka M., Grabiec M., Sadlecki P., et al. 25(OH)D3 in patients with ovarian cancer and its correlation with survival. Clin Biochem. 2012; 45 (18): 1568–72. https://doi.org/10.1016/j.clinbiochem.2012.07.110.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Seraphin G., Rieger S., Hewison M., et al. The impact of vitamin D on cancer: a mini review. J Steroid Biochem Mol Biol. 2023; 231: 106308. https://doi.org/10.1016/j.jsbmb.2023.106308.</mixed-citation><mixed-citation xml:lang="en">Seraphin G., Rieger S., Hewison M., et al. The impact of vitamin D on cancer: a mini review. J Steroid Biochem Mol Biol. 2023; 231: 106308. https://doi.org/10.1016/j.jsbmb.2023.106308.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang X., Niu W. Meta-analysis of randomized controlled trials on vitamin D supplement and cancer incidence and mortality. Biosci Rep. 2019; 39 (11): BSR20190369. https://doi.org/10.1042/BSR20190369.</mixed-citation><mixed-citation xml:lang="en">Zhang X., Niu W. Meta-analysis of randomized controlled trials on vitamin D supplement and cancer incidence and mortality. Biosci Rep. 2019; 39 (11): BSR20190369. https://doi.org/10.1042/BSR20190369.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Южакова Д.В., Ширманова М.В., Сергеева Т.Ф. и др. Иммунотерапия злокачественных новообразований (обзор). Современные технологии в медицине. 2016; 8 (1): 173–82. https://doi.org/10.17691/stm2016.8.1.23.</mixed-citation><mixed-citation xml:lang="en">Yuzhakova D.V., Shirmanova M.V., Sergeeva T.F., et al. Immunotherapy of cancer (review). SOVREMENNYE tehnologii V medicine / Modern Technologies in Medicine. 2016; 8 (1): 173–82 (in Russ.). https://doi.org/10.17691/stm2016.8.1.23.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Hoenig H., Nusbaum N., Brummel-Smith K. Geriatric rehabilitation: state of the art. J Am Geriatr Soc. 1997; 45 (11): 1371–81. https://doi.org/10.1111/j.1532-5415.1997.tb02939.x.</mixed-citation><mixed-citation xml:lang="en">Hoenig H., Nusbaum N., Brummel-Smith K. Geriatric rehabilitation: state of the art. J Am Geriatr Soc. 1997; 45 (11): 1371–81. https://doi.org/10.1111/j.1532-5415.1997.tb02939.x.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Г., Табакман Ю.Ю., Идрисова Л.Э., Сдвижков А.М. Реабилитация онкогинекологических больных. Взгляд на проблему. Акушерство, гинекология и репродукция. 2016; 9 (4): 46–54. https://doi.org/10.17749/2070-4968.2015.9.4.046-054.</mixed-citation><mixed-citation xml:lang="en">Solopova A.G., Tabakman Yu.Yu., Idrisova L.E., Sdvizhkov A.M. Rehabilitation of onсogyneсologic patients. View of a problem. Obstetrics, Gynecology and Reproduction. 2016; 9 (4): 46–54 (in Russ.). https://doi.org/10.17749/2070-4968.2015.9.4.046-054.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Jacob M.E., Marron M.M., Boudreau R.M., et al. Age, race, and gender factors in incident disability. J Gerontol A Biol Sci Med Sci. 2018; 73 (2): 194–7. https://doi.org/10.1093/gerona/glx194.</mixed-citation><mixed-citation xml:lang="en">Jacob M.E., Marron M.M., Boudreau R.M., et al. Age, race, and gender factors in incident disability. J Gerontol A Biol Sci Med Sci. 2018; 73 (2): 194–7. https://doi.org/10.1093/gerona/glx194.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Основные факторы риска, приводящие к инвалидности в престарелом возрасте, и меры ее профилактики? Всемирная организация здравоохранения. 2003. URL: https://iris.who.int/bitstream/handle/10665/363771/9789289057424-rus.pdf?sequence=1&amp;isAllowed=y (дата обращения 30.09.2023).</mixed-citation><mixed-citation xml:lang="en">What are the main risk factors for disability in old age and how can disability be prevented? World Health Organization. 2003. Available at: https://iris.who.int/bitstream/handle/10665/363770/9789289057417-eng.pdf?sequence=1 (accessed 30.09.2023).</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">ICF beginner’s guide: towards a common language for functioning, disability and health. World Health Organization. 2002. URL: https://cdn.who.int/media/docs/default-source/classification/icf/icfbeginnersguide.pdf?sfvrsn=eead63d3_4&amp;download=true (дата обращения 30.09.2023).</mixed-citation><mixed-citation xml:lang="en">ICF beginner’s guide: towards a common language for functioning, disability and health. World Health Organization. 2002. Available at: https://cdn.who.int/media/docs/default-source/classification/icf/icfbeginnersguide.pdf?sfvrsn=eead63d3_4&amp;download=true (accessed 30.09.2023).</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Chan J.K., Kapp D.S., Shin J.Y., et al. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol. 2007; 109 (6): 1342. https://doi.org/10.1097/01.AOG.0000265207.27755.28.</mixed-citation><mixed-citation xml:lang="en">Chan J.K., Kapp D.S., Shin J.Y., et al. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol. 2007; 109 (6): 1342. https://doi.org/10.1097/01.AOG.0000265207. 27755.28.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Кулавский В.А., Кулавский Е.В., Зиганшин А.М. Хирургическая менопауза у женщин репродуктивного возраста. Акушерство, гинекология и репродукция. 2017; 10 (4): 105–13. https://doi.org/10.17749/2313-7347.2016.10.4.105-113.</mixed-citation><mixed-citation xml:lang="en">Kulavskii V.A., Kulavskii E.V., Ziganshin A.M. Surgical menopause in women of reproductive age. Obstetrics, Gynecology and Reproduction. 2017; 10 (4): 105–13 (in Russ.). https://doi.org/10.17749/23137347.2016.10.4.105-113.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Anwar S.L., Adistyawan G., Wulaningsih W., et al. Rehabilitation for cancer survivors: how we can reduce the healthcare service inequality in lowand middle-income countries. Am J Phys Med Rehabil. 2018; 97 (10): 764–71. https://doi.org/10.1097/PHM.0000000000000982.</mixed-citation><mixed-citation xml:lang="en">Anwar S.L., Adistyawan G., Wulaningsih W., et al. Rehabilitation for cancer survivors: how we can reduce the healthcare service inequality in lowand middle-income countries. Am J Phys Med Rehabil. 2018; 97 (10): 764–71. https://doi.org/10.1097/PHM.0000000000000982.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Weare K. Rehabilitation after gynecological cancer treatment. Int J Gynaecol Obstet. 2015; 131 (Suppl. 2): S164–6. https://doi.org/10.1016/j.ijgo.2015.06.015.</mixed-citation><mixed-citation xml:lang="en">Weare K. Rehabilitation after gynecological cancer treatment. Int J Gynaecol Obstet. 2015; 131 (Suppl. 2): S164–6. https://doi.org/10.1016/j.ijgo.2015.06.015.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Falandry C., Fauvet R., Alfonsi P., et al. Combining prehabilitation with enhanced recovery programs in gynecological surgery. J Gynecol Obstet Hum Reprod. 2022; 51 (5): 102376. https://doi.org/10.1016/j.jogoh.2022.102376.</mixed-citation><mixed-citation xml:lang="en">Falandry C., Fauvet R., Alfonsi P., et al. Combining prehabilitation with enhanced recovery programs in gynecological surgery. J Gynecol Obstet Hum Reprod. 2022; 51 (5): 102376. https://doi.org/10.1016/j.jogoh.2022.102376.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Miralpeix E., Mancebo G., Gayete S., et al. Role and impact of multimodal prehabilitation for gynecologic oncology patients in an Enhanced Recovery After Surgery (ERAS) program. Int J Gynecol Cancer. 2019; 29 (8): 1235–43. https://doi.org/10.1136/ijgc-2019-000597.</mixed-citation><mixed-citation xml:lang="en">Miralpeix E., Mancebo G., Gayete S., et al. Role and impact of multimodal prehabilitation for gynecologic oncology patients in an Enhanced Recovery After Surgery (ERAS) program. Int J Gynecol Cancer. 2019; 29 (8): 1235–43. https://doi.org/10.1136/ijgc-2019-000597.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Vonk Noordegraaf A., Anema J.R., van Mechelen W., et al. A personalised eHealth programme reduces the duration until return to work after gynaecological surgery: results of a multicentre randomised trial. BJOG. 2014; 121 (9): 1127–35. https://doi.org/10.1111/1471-0528.12661.</mixed-citation><mixed-citation xml:lang="en">Vonk Noordegraaf A., Anema J.R., van Mechelen W., et al. A personalised eHealth programme reduces the duration until return to work after gynaecological surgery: results of a multicentre randomised trial. BJOG. 2014; 121 (9): 1127–35. https://doi.org/10.1111/1471-0528.12661.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Nelson G., Altman A.D., Nick A., et al. Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations – Part II. Gynecol Oncol. 2016; 140 (2): 323–32. https://doi.org/10.1016/j.ygyno.2015.12.019.</mixed-citation><mixed-citation xml:lang="en">Nelson G., Altman A.D., Nick A., et al. Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations – Part II. Gynecol Oncol. 2016; 140 (2): 323–32. https://doi.org/10.1016/j.ygyno.2015.12.019.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Nelson G., Altman A.D., Nick A., et al. Guidelines for preand intraoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations – Part I. Gynecol Oncol. 2016; 140 (2): 313–22. https://doi.org/10.1016/j.ygyno.2015.11.015.</mixed-citation><mixed-citation xml:lang="en">Nelson G., Altman A.D., Nick A., et al. Guidelines for preand intraoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations – Part I. Gynecol Oncol. 2016; 140 (2): 313–22. https://doi.org/10.1016/j.ygyno.2015.11.015.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Hawkes A.L., Quinn M., Gebski V., et al. Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial. Contemp Clin Trials. 2014; 39 (1): 14–21. https://doi.org/10.1016/j.cct.2014.06.014.</mixed-citation><mixed-citation xml:lang="en">Hawkes A.L., Quinn M., Gebski V., et al. Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial. Contemp Clin Trials. 2014; 39 (1): 14–21. https://doi.org/10.1016/j.cct.2014.06.014.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Accredited European Training Centres in Gynaecological Oncology. European Society of Gynaecological Oncology. URL: https://esgo.org/esgo-ebcog-accredited-centres/ (дата обращения 11.08.2023).</mixed-citation><mixed-citation xml:lang="en">Accredited European Training Centres in Gynaecological Oncology. European Society of Gynaecological Oncology. Available at: https://esgo.org/esgo-ebcog-accredited-centres/ (accessed 11.08.2023).</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Falcicchio C., Di Lallo D., Fabi A., et al. Use of rehabilitation pathways in women with breast cancer in the first 12 months of the disease: a retrospective study. BMC Cancer. 2021; 21 (1): 311. https://doi.org/10.1186/s12885-021-07927-0.</mixed-citation><mixed-citation xml:lang="en">Falcicchio C., Di Lallo D., Fabi A., et al. Use of rehabilitation pathways in women with breast cancer in the first 12 months of the disease: a retrospective study. BMC Cancer. 2021; 21 (1): 311. https://doi.org/10.1186/s12885-021-07927-0.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Thorsen L., Gjerset G.M., Loge J.H., et al. Cancer patients’ needs for rehabilitation services. Acta Oncol. 2011; 50 (2): 212–22. https://doi.org/10.3109/0284186X.2010.531050.</mixed-citation><mixed-citation xml:lang="en">Thorsen L., Gjerset G.M., Loge J.H., et al. Cancer patients’ needs for rehabilitation services. Acta Oncol. 2011; 50 (2): 212–22. https://doi.org/10.3109/0284186X.2010.531050.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Butow P.N., Price M.A., Bell M.L., et al. Caring for women with ovarian cancer in the last year of life: a longitudinal study of caregiver quality of life, distress and unmet needs. Gynecol Oncol. 2014; 132 (3): 690–7. https://doi.org/10.1016/j.ygyno.2014.01.002.</mixed-citation><mixed-citation xml:lang="en">Butow P.N., Price M.A., Bell M.L., et al. Caring for women with ovarian cancer in the last year of life: a longitudinal study of caregiver quality of life, distress and unmet needs. Gynecol Oncol. 2014; 132 (3): 690–7. https://doi.org/10.1016/j.ygyno.2014.01.002.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Seland M., Skrede K., Lindemann K., et al. Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstet Gynecol Scand. 2022; 101 (3): 313–22. https://doi.org/10.1111/aogs.14310.</mixed-citation><mixed-citation xml:lang="en">Seland M., Skrede K., Lindemann K., et al. Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstet Gynecol Scand. 2022; 101 (3): 313–22. https://doi.org/10.1111/aogs.14310.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Holm L.V., Hansen D.G., Kragstrup J., et al. Influence of comorbidity on cancer patients’ rehabilitation needs, participation in rehabilitation activities and unmet needs: a population-based cohort study. Support Care Cancer. 2014; 22 (8): 2095–105. https://doi.org/10.1007/s00520-014-2188-1.</mixed-citation><mixed-citation xml:lang="en">Holm L.V., Hansen D.G., Kragstrup J., et al. Influence of comorbidity on cancer patients’ rehabilitation needs, participation in rehabilitation activities and unmet needs: a population-based cohort study. Support Care Cancer. 2014; 22 (8): 2095–105. https://doi.org/10.1007/s00520-014-2188-1.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
